Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.29	-221.87	-181.43
Graham Fair Price	-14.55	1.38	1.62
PEG	6.87	1.05	-0.98
Price/Book	-22.81	5.87	7.61
Price/Cash Flow	33.17	847.33	-636.30
Prices/Earnings	6.38	-23.47	-25.07
Price/Sales	-20.84	38.62	48.79
Price/FCF	33.17	847.33	-636.30
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-73.51	0.03	-0.13
Operating Margin	12.86	-0.42	-0.48
ROA	20.59	-0.04	-0.04
ROE	-0.08	-0.06	17.55
ROIC	-0.05	-0.05	2.60
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.10	0.23	-55.03
Dividends QOQ	0.07	0.03	-56.41
EBIT QOQ	-0.25	0.20	-20.03
EPS QOQ	-0.26	0.22	-12.39
FCF QOQ	-0.54	1.55	186.20
Revenue QOQ	0.22	-0.08	-62.06
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	110.45	149.94	35.76
Days Sales Outstanding (DSO)	153.68	144.16	-6.19
Inventory Turnover	0.81	0.60	-26.34
Debt/Capitalization	0.30	0.29	-3.06
Quick Ratio	0.98	0.83	-15.21
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.24	1.17	-5.89
Cash	0.23	0.23	-2.90
Capex	-0.01	< 0.005	93.74
Free Cash Flow	-0.01	< 0.005	-45.45
Revenue	0.19	0.18	-8.24
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.45	1.35	-7.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.91	-8.34	-41.05
Naive Interpretation	Member

06 - Financial Health · Weak

Rating